Stifel Reports Second Quarter 2025 Results

(NYSE:SF), ST. LOUIS, July 30, 2025 (GLOBE NEWSWIRE) — Stifel Financial Corp. (NYSE: SF) today reported net revenues of $1.3 billion for the three months ended June 30, 2025, compared with $1.2 billion a year ago. Net income available to common shareholders was $145.7 million, or $1.34 per diluted common share, compared with $156.0 million, […]

Stepan Reports Second Quarter 2025 Results

Stepan Company (NYSE: SCL) today reported: https://mma.prnewswire.com/media/2401084/Stepan_Company_Logo.jpg Second Quarter 2025 Highlights — Reported net income was $11.3 million, up 19% versus the prior year. Adjusted net income(1) was $12.0 million, up 27% versus the prior year, driven by earnings growth within Polymers, our Crop Productivity business and a lower effective tax rate. — EBITDA(2) was

NexGold Intersects 40.09 g/t gold over 17.7 Metres at the Goldboro Open Pit Gold Project

(TSX-V:NEXG),(OTC US:NXGCF),(OTCQX:NXGCF), TORONTO, July 30, 2025 (GLOBE NEWSWIRE) — NexGold Mining Corp. (TSXV: NEXG; OTCQX: NXGCF) (“NexGold” or the “Company“) is pleased to provide additional drill results from a recently-completed 26,854-metre diamond drill program initially announced on January 22, 2025 at the Company's Goldboro Open Pit Gold Project (“Goldboro“) in Nova Scotia. The drill program

Anika Reports Topline Results from U.S. Pivotal FastTRACK Phase III Study for Hyalofast(R) Cartilage Repair Scaffold and Provides Program Update

(NASDAQ:ANIK), Hyalofast consistently demonstrated improvements over microfracture, but missed on statistical significance of the pre-specified co-primary endpoints of percent change in KOOS Pain and IKDC function Hyalofast showed statistically significant improvements over microfracture in pre-defined secondary endpoints and other measures that align with prior FDA approvals for cartilage repair products Hyalofast has been used to

Novasight(TM) Hybrid Imaging System Featured in Published JSCAI Case Report Demonstrating Superior Diagnosis and Precision-Guided Therapy in Complex Coronary Case

(TSX-V:CNVI),(OTC US:CNVIF),(OtherOTC:CNVIF), TORONTO, July 30, 2025 (GLOBE NEWSWIRE) — Conavi Medical Inc. (TSXV: CNVI) (OTCQB: CNVIF), a leader in hybrid intravascular imaging, is pleased to announce the publication of a compelling case report in the Journal of the Society for Cardiovascular Angiography & Interventions (JSCAI) highlighting the clinical impact of the Company's Novasight(TM) Hybrid IVUS-OCT

Telesat Schedules Second Quarter 2025 Earnings Conference Call for August 6, 2025

(TSX:TSAT),(NASDAQ:TSAT), OTTAWA, Ontario, July 30, 2025 (GLOBE NEWSWIRE) — Telesat (Nasdaq and TSX: TSAT), one of the world's largest and most innovative satellite operators, has scheduled a conference call on Wednesday, August 6, 2025, at 10:00 a.m. EDT to discuss its financial results for the three and six month periods ended June 30, 2025. The

ScottsMiracle-Gro Drives EBITDA and EPS Growth in Third Quarter; Gross Margin Improvement and Increase in U.S. Consumer Net Sales Fuel Gains

(NYSE:SMG), Company reaffirms full-year non-GAAP fiscal 2025 guidance U.S. Consumer net sales increased 1 percent and POS units increased 6 percent in fiscal third quarter GAAP gross margin rate of 31.8 percent and non-GAAP adjusted gross margin rate of 32.1 percent in third quarter improved by 230 and 290 basis points over prior year, respectively

Skye Bioscience to Announce Second Quarter 2025 Financial Results and Business Update on August 7, 2025

(NasdaqGM:SKYE), SAN DIEGO, July 30, 2025 (GLOBE NEWSWIRE) — Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biotechnology company focused on advancing new therapeutic pathways for obesity and other metabolic health disorders, will host a conference call on Thursday, August 7, 2025 at 1:30 p.m. PT/4:30 p.m. ET to discuss its second quarter 2025 financial

The Chefs’ Warehouse Reports Second Quarter 2025 Financial Results

(NASDAQ:CHEF), RIDGEFIELD, Conn., July 30, 2025 (GLOBE NEWSWIRE) — The Chefs' Warehouse, Inc. (NASDAQ: CHEF) (the “Company” or “Chefs'”), a premier distributor of specialty food products in the United States, the Middle East, and Canada, today reported financial results for its second quarter ended June 27, 2025. Financial highlights for the second quarter of 2025:

EyePoint to Report Second Quarter 2025 Financial Results on August 6, 2025

(NasdaqGM:EYPT), WATERTOWN, Mass., July 30, 2025 (GLOBE NEWSWIRE) — EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today announced it will host a conference call and live webcast at 8:30 a.m. ET on Wednesday, August 6, 2025 to report

Scroll to Top